BA Fundamental Analysis - BOEING CO/THE

Fundamental Rating

We assign a fundamental rating of 1 out of 10 to BA. BA was compared to 71 industry peers in the Aerospace & Defense industry. BA has a bad profitability rating. Also its financial health evaluation is rather negative. BA is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

BA had negative earnings in the past year.

In the past year BA has reported a negative cash flow from operations.

In the past 5 years BA always reported negative net income.

The reported operating cash flow has been mixed in the past 5 years: BA reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -6.78%, BA is not doing good in the industry: 69.01% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-6.78%
ROE	N/A
ROIC	N/A

ROA(3y)-4.27%

ROA(5y)-4.73%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BA has a worse Gross Margin (1.10%) than 84.51% of its industry peers.

BA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	1.1%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BA does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for BA has been increased compared to 1 year ago.

BA has more shares outstanding than it did 5 years ago.

BA has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.11, we must say that BA is in the distress zone and has some risk of bankruptcy.

BA has a worse Altman-Z score (1.11) than 76.06% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	1.11

ROIC/WACCN/A

WACC9.67%

2.3 Liquidity

A Current Ratio of 1.18 indicates that BA should not have too much problems paying its short term obligations.

BA has a worse Current ratio (1.18) than 77.46% of its industry peers.

A Quick Ratio of 0.38 indicates that BA may have some problems paying its short term obligations.

Looking at the Quick ratio, with a value of 0.38, BA is doing worse than 91.55% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.18
Quick Ratio	0.38

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

BA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.07%.

Looking at the last year, BA shows a quite strong growth in Revenue. The Revenue has grown by 10.18% in the last year.

Measured over the past years, BA shows a decrease in Revenue. The Revenue has been decreasing by -4.74% on average per year.

EPS 1Y (TTM)-1.07%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%28.45%

Revenue 1Y (TTM)10.18%

Revenue growth 3Y2.21%

Revenue growth 5Y-4.74%

Sales Q2Q%30.44%

3.2 Future

BA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.77% yearly.

Based on estimates for the next years, BA will show a quite strong growth in Revenue. The Revenue will grow by 14.75% on average per year.

EPS Next Y57.77%

EPS Next 2Y45.81%

EPS Next 3Y31.93%

EPS Next 5Y20.77%

Revenue Next Year30.02%

Revenue Next 2Y20.01%

Revenue Next 3Y17.45%

Revenue Next 5Y14.75%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BA. In the last year negative earnings were reported.

The Price/Forward Earnings ratio is 72.85, which means the current valuation is very expensive for BA.

Compared to the rest of the industry, the Price/Forward Earnings ratio of BA is on the same level as its industry peers.

BA is valuated expensively when we compare the Price/Forward Earnings ratio to 36.12, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	72.85

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

BA's earnings are expected to grow with 31.93% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y45.81%

EPS Next 3Y31.93%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BOEING CO/THE

NYSE:BA (11/26/2025, 6:57:03 PM)

After market: 187.17 +0.25 (+0.13%)

186.92

+4.48 (+2.46%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryAerospace & Defense

Earnings (Last)10-29 2025-10-29/bmo

Earnings (Next)01-26 2026-01-26/amc

Inst Owners74.41%

Inst Owner Change1.11%

Ins Owners0.03%

Ins Owner Change-0.11%

Market Cap142.08B

Revenue(TTM)80.76B

Net Income(TTM)-10.17B

Analysts82.86

Price Target258.01 (38.03%)

Short Float %2.03%

Short Ratio1.86

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-19.63%

Min EPS beat(2)-57.93%

Max EPS beat(2)18.67%

EPS beat(4)2

Avg EPS beat(4)-16.78%

Min EPS beat(4)-91.07%

Max EPS beat(4)63.2%

EPS beat(8)5

Avg EPS beat(8)-3.37%

EPS beat(12)6

Avg EPS beat(12)-66.45%

EPS beat(16)6

Avg EPS beat(16)-757.66%

Revenue beat(2)2

Avg Revenue beat(2)1.97%

Min Revenue beat(2)1.11%

Max Revenue beat(2)2.82%

Revenue beat(4)2

Avg Revenue beat(4)-1.87%

Min Revenue beat(4)-8.71%

Max Revenue beat(4)2.82%

Revenue beat(8)3

Avg Revenue beat(8)-1.85%

Revenue beat(12)4

Avg Revenue beat(12)-1.59%

Revenue beat(16)4

Avg Revenue beat(16)-4.27%

PT rev (1m)-2.36%

PT rev (3m)-0.69%

EPS NQ rev (1m)-2576.01%

EPS NQ rev (3m)-1420.61%

EPS NY rev (1m)-72.89%

EPS NY rev (3m)-374.34%

Revenue NQ rev (1m)-1.33%

Revenue NQ rev (3m)-1.16%

Revenue NY rev (1m)1.15%

Revenue NY rev (3m)3%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	72.85
P/S	1.76
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-15.1

EYN/A

EPS(NY)2.57

Fwd EY1.37%

FCF(TTM)-8.35

FCFYN/A

OCF(TTM)-4.89

OCFYN/A

SpS106.25

BVpS-10.85

TBVpS-22.4

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.78%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	1.1%
FCFM	N/A

ROA(3y)-4.27%

ROA(5y)-4.73%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.54

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	136.76%
Cap/Sales	3.26%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.18
Quick Ratio	0.38
Altman-Z	1.11

F-Score4

WACC9.67%

ROIC/WACCN/A

Cap/Depr(3y)90.02%

Cap/Depr(5y)74.76%

Cap/Sales(3y)2.43%

Cap/Sales(5y)2.22%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-1.07%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%28.45%

EPS Next Y57.77%

EPS Next 2Y45.81%

EPS Next 3Y31.93%

EPS Next 5Y20.77%

Revenue 1Y (TTM)10.18%

Revenue growth 3Y2.21%

Revenue growth 5Y-4.74%

Sales Q2Q%30.44%

Revenue Next Year30.02%

Revenue Next 2Y20.01%

Revenue Next 3Y17.45%

Revenue Next 5Y14.75%

EBIT growth 1Y-25.36%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year140.25%

EBIT Next 3Y49.38%

EBIT Next 5Y32.37%

FCF growth 1Y-237.62%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-161.56%

OCF growth 3YN/A

OCF growth 5YN/A

BOEING CO/THE / BA FAQ

Can you provide the ChartMill fundamental rating for BOEING CO/THE?

ChartMill assigns a fundamental rating of 1 / 10 to BA.

What is the valuation status of BOEING CO/THE (BA) stock?

ChartMill assigns a valuation rating of 2 / 10 to BOEING CO/THE (BA). This can be considered as Overvalued.

Can you provide the profitability details for BOEING CO/THE?

BOEING CO/THE (BA) has a profitability rating of 0 / 10.

How financially healthy is BOEING CO/THE?

The financial health rating of BOEING CO/THE (BA) is 1 / 10.

BOEING CO/THE (BA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

BOEING CO/THE / BA FAQ

Can you provide the ChartMill fundamental rating for BOEING CO/THE?

What is the valuation status of BOEING CO/THE (BA) stock?

Can you provide the profitability details for BOEING CO/THE?

How financially healthy is BOEING CO/THE?